Who we are
Medicines for Europe
Purpose and Objectives
OUR VALUES
STRUCTURE
OUR MEMBERS
BECOME A MEMBER
CODE OF CONDUCT
DISCLOSURE
JOB OPPORTUNITIES
Key topics
COVID-19
Access
INDUSTRIAL POLICY
REGULATORY AND LEGAL FRAMEWORK
FALSIFIED MEDICINES
ENVIRONMENT
ANTIMICROBIAL RESISTANCE
MEDICINE SHORTAGES
Publications
Factsheets
Infographics
Reports
Policy
Videos
Newsroom
Press releases
In the news
Press kit
Contact us
Login
Generic medicines
Home
Who we are
Generic medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Biosimilar medicines
Home
Who we are
Biosimilar medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
DEFINITION
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
External resources
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Value added medicines
Home
Who we are
Value added medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Environment of value added medicines in Europe
Definition
THERAPEUTIC AREAS
Q&A
What’s new
Environment of value added medicines in Europe
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Value Added Medicines award 2019
QUOTES
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Contact us
Events
What's new
By type
External Resources
Factsheets
Infographics
Membership
Policy
Quotes
Reports
UAH
Videos
By year
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
Newsroom
Twitter
Tweets
Videos
Photos
LESSONS LEARNED FROM COVID-19 – POLICY PAPER
22 June 2020
Policy
Open
Quotes from 3rd VAM conference
3 June 2020
Quote
Read more
Physicians recognised potential of Value Added Medicines
3 June 2020
Infographic
Open
Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic
10 April 2020
External Resource
Open
Perceptions and recommendations of physicians/KOLs on value added medicines
21 November 2019
Report
Open
The secret to improve access to value added medicines
14 November 2019
Policy
Open
Improving healthcare delivery in hospitals by optimized utilization of medicines
7 October 2019
Report
Open
A digital future for value added medicines
24 September 2019
Policy, Report
Open
How can your healthcare system support a wider access to Value Added Medicines?
27 May 2019
Infographic
Open
Annual Medicines for Europe and IGBA Conference 2019
4 April 2019
Video
View
Posts navigation
1
2
3
4
…
6
Subscribe to our newsletter
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
